Category: Press Release - Page 7 - Psychedelic Alpha

Read more about the article Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Post published:August 1, 2023
Post category:Press Release

Read more about the article Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

Post published:August 1, 2023
Post category:Press Release

Read more about the article COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023

COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023

Post published:July 31, 2023
Post category:Press Release

Read more about the article Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents

Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents

Post published:July 28, 2023
Post category:Press Release

Read more about the article MIND CURE ANNOUNCES LNG ENERGY GROUP CREDIT AGREEMENT IN THE AMOUNT OF U.S. $70 MILLION TO ACQUIRE LEWIS ENERGY COLOMBIA, INC.

MIND CURE ANNOUNCES LNG ENERGY GROUP CREDIT AGREEMENT IN THE AMOUNT OF U.S. $70 MILLION TO ACQUIRE LEWIS ENERGY COLOMBIA, INC.

Post published:July 28, 2023
Post category:Press Release

Read more about the article Small Pharma Reports Fiscal First Quarter 2024 Highlights

Small Pharma Reports Fiscal First Quarter 2024 Highlights

Post published:July 28, 2023
Post category:Press Release

Read more about the article Optimi Health Announces Receipt of Purported Termination Notice

Optimi Health Announces Receipt of Purported Termination Notice

Post published:July 27, 2023
Post category:Press Release

Read more about the article First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine

First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine

Post published:July 25, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES UPSIZING AND CLOSING OF $2,500,000 NON-BROKERED PRIVATE PLACEMENT FINANCING

FILAMENT HEALTH ANNOUNCES UPSIZING AND CLOSING OF $2,500,000 NON-BROKERED PRIVATE PLACEMENT FINANCING

Post published:July 24, 2023
Post category:Press Release

Read more about the article Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Post published:July 20, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.